498 related articles for article (PubMed ID: 12149225)
1. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
3. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
[TBL] [Abstract][Full Text] [Related]
4. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
5. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
[TBL] [Abstract][Full Text] [Related]
6. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.
Lin K; Sherrington PD; Dennis M; Matrai Z; Cawley JC; Pettitt AR
Blood; 2002 Aug; 100(4):1404-9. PubMed ID: 12149224
[TBL] [Abstract][Full Text] [Related]
7. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
[TBL] [Abstract][Full Text] [Related]
8. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
9. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
10. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
12. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
Cuneo A; Rigolin GM; Bigoni R; De Angeli C; Veronese A; Cavazzini F; Bardi A; Roberti MG; Tammiso E; Agostini P; Ciccone M; Della Porta M; Tieghi A; Cavazzini L; Negrini M; Castoldi G
Leukemia; 2004 Mar; 18(3):476-83. PubMed ID: 14712287
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
Ferrajoli A; Keating MJ; Manshouri T; Giles FJ; Dey A; Estrov Z; Koller CA; Kurzrock R; Thomas DA; Faderl S; Lerner S; O'Brien S; Albitar M
Blood; 2002 Aug; 100(4):1215-9. PubMed ID: 12149200
[TBL] [Abstract][Full Text] [Related]
16. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
Zenz T; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
[TBL] [Abstract][Full Text] [Related]
17. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin V genes and CD38 expression in CLL.
Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
[No Abstract] [Full Text] [Related]
20. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]